Search results
Results from the WOW.Com Content Network
BrightFocus Foundation is a nonprofit organization based in Clarksburg, Maryland.BrightFocus funds research in an effort to discover cures for Alzheimer's disease, macular degeneration and glaucoma, and provides information and free English and Spanish resources to increase awareness about these diseases.
Early Manifest Glaucoma Trial: This study evaluated the effects of reducing eye pressure versus no treatment or late treatment for early open-angle glaucoma. It showed that reducing eye pressure can be valuable as early glaucoma treatment—but when to offer this treatment should be decided on a case-by-case basis.
The team says that the method needs more development before its suitability for use on humans is determined, notes LiveScience. Thus far, they believe it could be a treatment for reversing vision ...
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.
Novartis' eye care unit Alcon is withdrawing a surgical stent for glaucoma patients after clinical data showed it may damage the eye, but the Swiss drugmaker said the move would not affect plans ...
Trabeculectomy is the most common invasive glaucoma surgery. It is highly effective in the treatment of advanced glaucoma as demonstrated in major glaucoma studies. [citation needed] Even if a prior trabeculectomy has failed a second trabeculectomy can be performed at a different site. If scarring is the main reason, anti-fibrotic and anti ...
Research also suggests that people who have glaucoma are at a higher risk for Alzheimer’s disease, Dr. Law says. “It’s a degenerative process,” he adds. “Our body is constantly in a ...
Micro-invasive glaucoma surgery (MIGS) is the latest advance in surgical treatment for glaucoma, which aims to reduce intraocular pressure by either increasing outflow of aqueous humor or reducing its production. MIGS comprises a group of surgical procedures which share common features. [1]